# SpliSense

**Source:** https://www.startuphub.ai/startups/splisense
**Profile type:** Startup

> Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

## About

SpliSense is a biotechnology company developing transformative RNA-based treatments for pulmonary diseases. Their innovative therapies utilize Antisense Oligonucleotides (ASOs) to restore and modify protein functionality, targeting the root cause of conditions like Cystic Fibrosis and Muco-Obstructive Pulmonary Diseases.

## Key facts

- **Slug:** splisense
- **Website:** http://www.splisense.com
- **Location:** Rehovot, Israel
- **Founded:** 2017-02-01 00:00:00
- **Employees:** 16
- **Operating status:** Active
- **Total funding:** $29M
- **Sectors / tags:** Healthcare, Lung, Treatment, Biotech, Cystic Fibrosis, mRNA, MedTech, HealthTech, Genomics, Drug Discovery, Clinical Trials, Precision Medicine, Gene Therapy
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/splisenseltd/

## Frequently asked

### What does SpliSense do?

SpliSense is a biotechnology company developing transformative RNA-based treatments for pulmonary diseases. Their innovative therapies utilize Antisense Oligonucleotides (ASOs) to restore and modify protein functionality, targeting the root cause of conditions like Cystic Fibrosis and Muco-Obstructive Pulmonary Diseases.

### How much funding has SpliSense raised?

SpliSense has raised a total of $29M in funding. The most recent round on record is Series B.

### Where is SpliSense headquartered?

SpliSense is headquartered in Rehovot, Israel.

### When was SpliSense founded?

SpliSense was founded in 2017.

### What industry does SpliSense operate in?

SpliSense operates in Healthcare, Lung, Treatment, Biotech, Cystic Fibrosis, mRNA.

### How many employees does SpliSense have?

SpliSense has approximately 16 people on record.

### What is SpliSense's revenue?

StartupHub estimates SpliSense's annual revenue at $3.3M (range $1.8M to $9.8M, 64% confidence), based on comparable companies in the sector.

### What is SpliSense's valuation?

StartupHub estimates SpliSense's effective valuation at $114.0M (range $71.3M to $171.0M, 10% confidence), based on comparable companies in the sector.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "SpliSense",
          "item": "https://www.startuphub.ai/startups/splisense"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/splisense#webpage",
      "url": "https://www.startuphub.ai/startups/splisense",
      "name": "SpliSense - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of SpliSense. SpliSense is a startup founded in 2017, operating in Healthcare and Lung. Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis. Headquartered in Rehovot, Israel. The company has approximately 16 employees.",
      "dateModified": "2026-06-22T04:07:36.347+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/splisense#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/splisense#organization",
      "name": "SpliSense",
      "url": "http://www.splisense.com",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/8b616edd-156c-4ed0-8170-ce7c868085a8-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/8b616edd-156c-4ed0-8170-ce7c868085a8-square.webp",
      "description": "This is the official profile of SpliSense. SpliSense is a startup founded in 2017, operating in Healthcare and Lung. Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis. Headquartered in Rehovot, Israel. The company has approximately 16 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/splisenseltd/",
        "https://www.startuphub.ai/startups/splisense"
      ],
      "foundingDate": "2017-02-01 00:00:00",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 16
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Rehovot",
        "addressCountry": "Israel"
      },
      "knowsAbout": [
        "Healthcare",
        "Lung",
        "Treatment",
        "Biotech",
        "Cystic Fibrosis",
        "mRNA",
        "MedTech",
        "HealthTech",
        "Genomics",
        "Drug Discovery",
        "Clinical Trials",
        "Precision Medicine",
        "Gene Therapy"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/splisense#profile-assessment",
      "name": "SpliSense - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/splisense",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/8b616edd-156c-4ed0-8170-ce7c868085a8-square.webp",
      "category": "Healthcare",
      "description": "This is the official profile of SpliSense. SpliSense is a startup founded in 2017, operating in Healthcare and Lung. Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis. Headquartered in Rehovot, Israel. The company has approximately 16 employees. Agent Readiness score: 32/100. Full audit: https://www.startuphub.ai/startups/splisense/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "SpliSense"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-06-22",
        "name": "SpliSense - Profile Score 54/100",
        "reviewBody": "This is the official profile of SpliSense. SpliSense is a startup founded in 2017, operating in Healthcare and Lung. Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis. Headquartered in Rehovot, Israel. The company has approximately 16 employees. Agent Readiness score: 32/100. Full audit: https://www.startuphub.ai/startups/splisense/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 54,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```